Tibet Cheezheng Tibetan Medicine Co Ltd (002287) — Strategic Asset Allocation Index
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Strategic Asset Allocation Index of 37.0% as of September 2023. Strategic assets (PP&E of CN¥1.32 Billion plus long-term investments of CN¥-) total CN¥1.32 Billion, measured against net assets of CN¥3.56 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Tibet Cheezheng Tibetan Medicine Co Ltd (002287) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Tibet Cheezheng Tibetan Medicine Co Ltd Strategic Asset Allocation Index (2008–2022)
This chart shows how Tibet Cheezheng Tibetan Medicine Co Ltd's Strategic Asset Allocation Index has evolved across 15 annual periods from 2008 to 2022. As of September 2023, the index stands at 37.0%, representing strategic assets of CN¥1.32 Billion against net assets of CN¥3.56 Billion CNY. For live market cap and overall valuation, see Tibet Cheezheng Tibetan Medicine Co Ltd stock valuation.
Annual Strategic Asset Allocation Index for Tibet Cheezheng Tibetan Medicine Co Ltd (2008–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Tibet Cheezheng Tibetan Medicine Co Ltd from 2008 to 2022, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 002287 total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.8% | CN¥1.14 Billion | CN¥1.14 Billion | CN¥- | CN¥3.39 Billion | ▲ +8.3 pp |
| 2021 | 25.5% | CN¥821.35 Million | CN¥821.35 Million | CN¥- | CN¥3.22 Billion | ▲ +3.5 pp |
| 2020 | 22.0% | CN¥579.11 Million | CN¥579.11 Million | CN¥- | CN¥2.63 Billion | ▼ -2.1 pp |
| 2019 | 24.1% | CN¥545.72 Million | CN¥545.72 Million | CN¥- | CN¥2.26 Billion | ▼ -10.8 pp |
| 2018 | 34.9% | CN¥713.53 Million | CN¥488.38 Million | CN¥225.15 Million | CN¥2.05 Billion | ▲ +0.9 pp |
| 2017 | 34.0% | CN¥644.20 Million | CN¥404.20 Million | CN¥240.00 Million | CN¥1.89 Billion | ▲ +2.0 pp |
| 2016 | 32.0% | CN¥560.38 Million | CN¥322.88 Million | CN¥237.50 Million | CN¥1.75 Billion | ▼ -3.4 pp |
| 2015 | 35.4% | CN¥585.12 Million | CN¥347.62 Million | CN¥237.50 Million | CN¥1.65 Billion | ▲ +16.6 pp |
| 2014 | 18.9% | CN¥292.37 Million | CN¥292.37 Million | CN¥- | CN¥1.55 Billion | ▼ -3.2 pp |
| 2013 | 22.1% | CN¥319.78 Million | CN¥319.78 Million | CN¥- | CN¥1.45 Billion | ▲ +3.3 pp |
| 2012 | 18.8% | CN¥253.47 Million | CN¥253.47 Million | CN¥- | CN¥1.35 Billion | ▲ +0.8 pp |
| 2011 | 17.9% | CN¥228.79 Million | CN¥228.79 Million | CN¥- | CN¥1.28 Billion | ▲ +5.6 pp |
| 2010 | 12.3% | CN¥149.20 Million | CN¥149.20 Million | CN¥- | CN¥1.21 Billion | ▲ +2.1 pp |
| 2009 | 10.2% | CN¥116.63 Million | CN¥116.63 Million | CN¥- | CN¥1.14 Billion | ▼ -8.9 pp |
| 2008 | 19.1% | CN¥101.52 Million | CN¥101.52 Million | CN¥- | CN¥532.28 Million | — |